BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

9 articles for M Empting

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Towards the evaluation in an animal disease model: Fluorinated 17ß-HSD1 inhibitors showing strong activity towards both the human and the rat enzyme.EBI
Saarland University
Exploring the chemical space of ureidothiophene-2-carboxylic acids as inhibitors of the quorum sensing enzyme PqsD from Pseudomonas aeruginosa.EBI
Saarland University & Helmholtz Institute For Pharmaceutical Research Saarland (Hips)
Catechol-based substrates of chalcone synthase as a scaffold for novel inhibitors of PqsD.EBI
Institute For Pharmaceutical Research Saarland (Hips)
Inhibition of 17ß-HSD1: SAR of bicyclic substituted hydroxyphenylmethanones and discovery of new potent inhibitors with thioether linker.EBI
Saarland University
Discovery and optimization of thiazole-based quorum sensing inhibitors as potent blockers of Pseudomonas aeruginosa pathogenicity.EBI
Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS)
Novel Strategies for the Treatment of Pseudomonas aeruginosa Infections.EBI
Helmholtz Institute For Pharmaceutical Research Saarland (HIPS)
Phage display-based discovery of cyclic peptides against the broad spectrum bacterial anti-virulence target CsrA.EBI
Institute For Pharmaceutical Research Saarland (Hips)
Fragment-Based Discovery of a Qualified Hit Targeting the Latency-Associated Nuclear Antigen of the Oncogenic Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8.EBI
Institute For Pharmaceutical Research Saarland (Hips)-Helmholtz Centre For Infection Research (Hzi
Design and synthesis of novel lactate dehydrogenase a inhibitors by fragment-based lead generation.BDB
Astrazeneca